Cystic fibrosis-related diabetes testing in Tagliacozzo
Find health labs to test for Cystic fibrosis-related diabetes in Tagliacozzo and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Salus s.r.l. Frosinone
Viale Parigi, 3, 03100 Frosinone FR, Italia
30.1 km
Diabetes Test by F-Medical Group Frosinone
Via Armando Fabi, 41, 03100 Frosinone FR, Italia
30.1 km
Hemoglobin Test by Villa Gioia Casa di Cura Srl
Viale San Domenico, 1F, 03039 Sora FR, Italia
30.3 km
Unverified
A Diabetes Test costs €20.00
See Details
Hemoglobin Test by Centro S.T.S.
Via Giuseppe Ferri, 6, 03039 Sora FR, Italia
30.3 km
Verified
A Diabetes Test costs €30.00
See Details
Diabetes Test by Bianalisi - Biosystem Group
Via Massa di San Giuliano, 229, 00132 Roma RM, Italia
41.5 km
Diabetes Test by Laboratorio Sabino Srl
Via Servilia, 12, 02032 Fara in Sabina RI, Italia
28.7 km
Unverified
A Diabetes Test costs €23.00
See Details
Hemoglobin Test by Centro Raphael
Via Mattè Trucco, 00132 Roma RM, Italia
41.5 km
Diabetes Test by Clinimed - Laboratorio Analisi Centro Polispecialistico
Viale Fabrateria Vetus, 03023 Ceccano FR, Italia
34.8 km
Hemoglobin Test by Casa di Cura Roma INI - GROTTAFERRATA
Strada Provinciale Sant'Anna in Grottaferrata, 00046 Grottaferrata RM, Italia
35.9 km
Diabetes Test by Casa di Cura Privata Madonna delle Grazie S.p.a.
Viale Salvo D'Acquisto, 67, 00049 Velletri RM, Italia
36.1 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
